0001493152-21-029973.txt : 20211129
0001493152-21-029973.hdr.sgml : 20211129
20211129124633
ACCESSION NUMBER: 0001493152-21-029973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211124
FILED AS OF DATE: 20211129
DATE AS OF CHANGE: 20211129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silverman Joshua
CENTRAL INDEX KEY: 0001524858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 211454751
MAIL ADDRESS:
STREET 1: IROQUOIS CAPITAL MANAGEMENT LLC
STREET 2: 205 EAST 42ND ST - 20TH FL.
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0306
4
2021-11-24
0
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001524858
Silverman Joshua
855 N. WOLFE STREET, SUITE 623
BALTIMORE
MD
21205
1
0
0
0
Common Stock
2021-11-24
4
P
0
6734
6.2991
A
80509
D
Common Stock
2021-11-24
4
P
0
3266
7.0937
A
83775
D
Common Stock
2021-11-26
4
P
0
5000
7.5543
A
88775
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.96, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.17, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.70, inclusive.
/s/ Joshua Silverman
2021-11-29